nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP2C19—epilepsy syndrome	0.153	0.574	CbGaD
Cilostazol—CYP2D6—epilepsy syndrome	0.113	0.426	CbGaD
Cilostazol—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0202	0.0393	CbGbCtD
Cilostazol—CYP3A7—Carbamazepine—epilepsy syndrome	0.0169	0.0329	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0169	0.0329	CbGbCtD
Cilostazol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0163	0.0317	CbGbCtD
Cilostazol—CYP3A7—Phenytoin—epilepsy syndrome	0.0152	0.0295	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0152	0.0295	CbGbCtD
Cilostazol—CYP2C19—Felbamate—epilepsy syndrome	0.0151	0.0295	CbGbCtD
Cilostazol—CYP2C19—Trimethadione—epilepsy syndrome	0.0151	0.0295	CbGbCtD
Cilostazol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0142	0.0277	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0135	0.0263	CbGbCtD
Cilostazol—CYP3A7—Phenobarbital—epilepsy syndrome	0.0135	0.0263	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0133	0.026	CbGbCtD
Cilostazol—CYP3A7—Midazolam—epilepsy syndrome	0.0133	0.026	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0128	0.0249	CbGbCtD
Cilostazol—CYP3A7—Diazepam—epilepsy syndrome	0.0128	0.0249	CbGbCtD
Cilostazol—CYP3A5—Carbamazepine—epilepsy syndrome	0.0127	0.0247	CbGbCtD
Cilostazol—CYP2C19—Clobazam—epilepsy syndrome	0.0123	0.024	CbGbCtD
Cilostazol—CYP3A5—Phenytoin—epilepsy syndrome	0.0114	0.0222	CbGbCtD
Cilostazol—CYP2C19—Carbamazepine—epilepsy syndrome	0.0102	0.0199	CbGbCtD
Cilostazol—CYP3A5—Phenobarbital—epilepsy syndrome	0.0101	0.0197	CbGbCtD
Cilostazol—CYP3A5—Midazolam—epilepsy syndrome	0.00999	0.0195	CbGbCtD
Cilostazol—CYP3A5—Diazepam—epilepsy syndrome	0.00961	0.0187	CbGbCtD
Cilostazol—CYP2C19—Primidone—epilepsy syndrome	0.00955	0.0186	CbGbCtD
Cilostazol—CYP1A2—Carbamazepine—epilepsy syndrome	0.00944	0.0184	CbGbCtD
Cilostazol—CYP2C19—Phenytoin—epilepsy syndrome	0.00917	0.0179	CbGbCtD
Cilostazol—CYP1A2—Primidone—epilepsy syndrome	0.00881	0.0172	CbGbCtD
Cilostazol—CYP2C19—Propofol—epilepsy syndrome	0.00855	0.0167	CbGbCtD
Cilostazol—CYP2C19—Phenobarbital—epilepsy syndrome	0.00818	0.0159	CbGbCtD
Cilostazol—CYP1A2—Propofol—epilepsy syndrome	0.00789	0.0154	CbGbCtD
Cilostazol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00787	0.0153	CbGbCtD
Cilostazol—CYP2C19—Diazepam—epilepsy syndrome	0.00775	0.0151	CbGbCtD
Cilostazol—CYP3A5—Valproic Acid—epilepsy syndrome	0.00757	0.0148	CbGbCtD
Cilostazol—CYP2C19—Zonisamide—epilepsy syndrome	0.00756	0.0147	CbGbCtD
Cilostazol—CYP1A2—Phenobarbital—epilepsy syndrome	0.00754	0.0147	CbGbCtD
Cilostazol—CYP3A4—Trimethadione—epilepsy syndrome	0.00732	0.0143	CbGbCtD
Cilostazol—CYP3A4—Felbamate—epilepsy syndrome	0.00732	0.0143	CbGbCtD
Cilostazol—CYP1A2—Diazepam—epilepsy syndrome	0.00715	0.0139	CbGbCtD
Cilostazol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00688	0.0134	CbGbCtD
Cilostazol—CYP2D6—Propofol—epilepsy syndrome	0.0065	0.0127	CbGbCtD
Cilostazol—CYP3A4—Clonazepam—epilepsy syndrome	0.00622	0.0121	CbGbCtD
Cilostazol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00611	0.0119	CbGbCtD
Cilostazol—CYP3A4—Clobazam—epilepsy syndrome	0.00597	0.0116	CbGbCtD
Cilostazol—CYP1A2—Valproic Acid—epilepsy syndrome	0.00564	0.011	CbGbCtD
Cilostazol—CYP2C19—Topiramate—epilepsy syndrome	0.00551	0.0107	CbGbCtD
Cilostazol—CYP3A4—Rufinamide—epilepsy syndrome	0.00507	0.00988	CbGbCtD
Cilostazol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00494	0.00963	CbGbCtD
Cilostazol—CYP3A4—Primidone—epilepsy syndrome	0.00462	0.00899	CbGbCtD
Cilostazol—CYP3A4—Phenytoin—epilepsy syndrome	0.00443	0.00864	CbGbCtD
Cilostazol—CYP3A4—Propofol—epilepsy syndrome	0.00414	0.00806	CbGbCtD
Cilostazol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00395	0.0077	CbGbCtD
Cilostazol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00395	0.0077	CbGbCtD
Cilostazol—CYP3A4—Midazolam—epilepsy syndrome	0.0039	0.00759	CbGbCtD
Cilostazol—CYP3A4—Diazepam—epilepsy syndrome	0.00375	0.0073	CbGbCtD
Cilostazol—CYP3A4—Zonisamide—epilepsy syndrome	0.00366	0.00712	CbGbCtD
Cilostazol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00295	0.00575	CbGbCtD
Cilostazol—CYP3A4—Topiramate—epilepsy syndrome	0.00266	0.00519	CbGbCtD
Cilostazol—Aripiprazole—CHRM3—epilepsy syndrome	0.000562	0.179	CrCbGaD
Cilostazol—Aripiprazole—CHRM1—epilepsy syndrome	0.000524	0.167	CrCbGaD
Cilostazol—Aripiprazole—CHRM2—epilepsy syndrome	0.000428	0.137	CrCbGaD
Cilostazol—Aripiprazole—HTR7—epilepsy syndrome	0.000426	0.136	CrCbGaD
Cilostazol—Aripiprazole—ADRA2A—epilepsy syndrome	0.000365	0.117	CrCbGaD
Cilostazol—Aripiprazole—SLC6A4—epilepsy syndrome	0.000279	0.0889	CrCbGaD
Cilostazol—Aripiprazole—HTR2A—epilepsy syndrome	0.000214	0.0683	CrCbGaD
Cilostazol—Aripiprazole—CYP2D6—epilepsy syndrome	0.000196	0.0625	CrCbGaD
Cilostazol—Aripiprazole—ABCB1—epilepsy syndrome	0.00014	0.0446	CrCbGaD
Cilostazol—Asthenia—Clonazepam—epilepsy syndrome	4.55e-05	0.000241	CcSEcCtD
Cilostazol—Rhinitis—Topiramate—epilepsy syndrome	4.54e-05	0.000241	CcSEcCtD
Cilostazol—Back pain—Gabapentin—epilepsy syndrome	4.53e-05	0.00024	CcSEcCtD
Cilostazol—Headache—Fosphenytoin—epilepsy syndrome	4.53e-05	0.00024	CcSEcCtD
Cilostazol—Haemorrhage—Topiramate—epilepsy syndrome	4.53e-05	0.00024	CcSEcCtD
Cilostazol—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.52e-05	0.00024	CcSEcCtD
Cilostazol—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.52e-05	0.00024	CcSEcCtD
Cilostazol—Palpitations—Pregabalin—epilepsy syndrome	4.52e-05	0.00024	CcSEcCtD
Cilostazol—Asthenia—Phenytoin—epilepsy syndrome	4.52e-05	0.000239	CcSEcCtD
Cilostazol—Nausea—Midazolam—epilepsy syndrome	4.51e-05	0.000239	CcSEcCtD
Cilostazol—Hypoaesthesia—Topiramate—epilepsy syndrome	4.51e-05	0.000239	CcSEcCtD
Cilostazol—Muscle spasms—Gabapentin—epilepsy syndrome	4.51e-05	0.000239	CcSEcCtD
Cilostazol—Tachycardia—Valproic Acid—epilepsy syndrome	4.5e-05	0.000239	CcSEcCtD
Cilostazol—Diarrhoea—Zonisamide—epilepsy syndrome	4.5e-05	0.000239	CcSEcCtD
Cilostazol—Pharyngitis—Topiramate—epilepsy syndrome	4.5e-05	0.000238	CcSEcCtD
Cilostazol—Loss of consciousness—Pregabalin—epilepsy syndrome	4.49e-05	0.000238	CcSEcCtD
Cilostazol—Asthenia—Oxcarbazepine—epilepsy syndrome	4.49e-05	0.000238	CcSEcCtD
Cilostazol—Pruritus—Clonazepam—epilepsy syndrome	4.48e-05	0.000238	CcSEcCtD
Cilostazol—Vomiting—Vigabatrin—epilepsy syndrome	4.48e-05	0.000238	CcSEcCtD
Cilostazol—Skin disorder—Valproic Acid—epilepsy syndrome	4.48e-05	0.000238	CcSEcCtD
Cilostazol—Oedema peripheral—Topiramate—epilepsy syndrome	4.46e-05	0.000237	CcSEcCtD
Cilostazol—Cough—Pregabalin—epilepsy syndrome	4.46e-05	0.000237	CcSEcCtD
Cilostazol—Pruritus—Phenytoin—epilepsy syndrome	4.45e-05	0.000236	CcSEcCtD
Cilostazol—Nausea—Levetiracetam—epilepsy syndrome	4.45e-05	0.000236	CcSEcCtD
Cilostazol—Rash—Vigabatrin—epilepsy syndrome	4.44e-05	0.000236	CcSEcCtD
Cilostazol—Dizziness—Felbamate—epilepsy syndrome	4.44e-05	0.000236	CcSEcCtD
Cilostazol—Dermatitis—Vigabatrin—epilepsy syndrome	4.44e-05	0.000235	CcSEcCtD
Cilostazol—Pruritus—Oxcarbazepine—epilepsy syndrome	4.43e-05	0.000235	CcSEcCtD
Cilostazol—Headache—Vigabatrin—epilepsy syndrome	4.42e-05	0.000234	CcSEcCtD
Cilostazol—Hypertension—Pregabalin—epilepsy syndrome	4.41e-05	0.000234	CcSEcCtD
Cilostazol—Vomiting—Diazepam—epilepsy syndrome	4.41e-05	0.000234	CcSEcCtD
Cilostazol—Anorexia—Valproic Acid—epilepsy syndrome	4.4e-05	0.000233	CcSEcCtD
Cilostazol—Rash—Diazepam—epilepsy syndrome	4.38e-05	0.000232	CcSEcCtD
Cilostazol—Dermatitis—Diazepam—epilepsy syndrome	4.37e-05	0.000232	CcSEcCtD
Cilostazol—Myalgia—Pregabalin—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Chest pain—Pregabalin—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Arthralgia—Pregabalin—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Dizziness—Zonisamide—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Headache—Diazepam—epilepsy syndrome	4.35e-05	0.000231	CcSEcCtD
Cilostazol—Anxiety—Pregabalin—epilepsy syndrome	4.34e-05	0.00023	CcSEcCtD
Cilostazol—Diarrhoea—Clonazepam—epilepsy syndrome	4.34e-05	0.00023	CcSEcCtD
Cilostazol—Anaemia—Gabapentin—epilepsy syndrome	4.33e-05	0.00023	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.32e-05	0.000229	CcSEcCtD
Cilostazol—Hypotension—Valproic Acid—epilepsy syndrome	4.31e-05	0.000229	CcSEcCtD
Cilostazol—Asthenia—Carbamazepine—epilepsy syndrome	4.31e-05	0.000229	CcSEcCtD
Cilostazol—Diarrhoea—Phenytoin—epilepsy syndrome	4.31e-05	0.000228	CcSEcCtD
Cilostazol—Discomfort—Pregabalin—epilepsy syndrome	4.3e-05	0.000228	CcSEcCtD
Cilostazol—Nausea—Fosphenytoin—epilepsy syndrome	4.3e-05	0.000228	CcSEcCtD
Cilostazol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.28e-05	0.000227	CcSEcCtD
Cilostazol—Erythema multiforme—Topiramate—epilepsy syndrome	4.28e-05	0.000227	CcSEcCtD
Cilostazol—Vomiting—Felbamate—epilepsy syndrome	4.27e-05	0.000226	CcSEcCtD
Cilostazol—Pruritus—Carbamazepine—epilepsy syndrome	4.25e-05	0.000225	CcSEcCtD
Cilostazol—Rash—Felbamate—epilepsy syndrome	4.23e-05	0.000225	CcSEcCtD
Cilostazol—Dermatitis—Felbamate—epilepsy syndrome	4.23e-05	0.000224	CcSEcCtD
Cilostazol—Malaise—Gabapentin—epilepsy syndrome	4.23e-05	0.000224	CcSEcCtD
Cilostazol—Tinnitus—Topiramate—epilepsy syndrome	4.22e-05	0.000224	CcSEcCtD
Cilostazol—Vertigo—Gabapentin—epilepsy syndrome	4.21e-05	0.000223	CcSEcCtD
Cilostazol—Headache—Felbamate—epilepsy syndrome	4.21e-05	0.000223	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.2e-05	0.000223	CcSEcCtD
Cilostazol—Cardiac disorder—Topiramate—epilepsy syndrome	4.2e-05	0.000223	CcSEcCtD
Cilostazol—Syncope—Gabapentin—epilepsy syndrome	4.2e-05	0.000223	CcSEcCtD
Cilostazol—Leukopenia—Gabapentin—epilepsy syndrome	4.19e-05	0.000222	CcSEcCtD
Cilostazol—Dizziness—Clonazepam—epilepsy syndrome	4.19e-05	0.000222	CcSEcCtD
Cilostazol—Nausea—Vigabatrin—epilepsy syndrome	4.19e-05	0.000222	CcSEcCtD
Cilostazol—Vomiting—Zonisamide—epilepsy syndrome	4.18e-05	0.000222	CcSEcCtD
Cilostazol—Insomnia—Valproic Acid—epilepsy syndrome	4.17e-05	0.000221	CcSEcCtD
Cilostazol—Oedema—Pregabalin—epilepsy syndrome	4.17e-05	0.000221	CcSEcCtD
Cilostazol—Asthenia—Lamotrigine—epilepsy syndrome	4.17e-05	0.000221	CcSEcCtD
Cilostazol—Dizziness—Phenytoin—epilepsy syndrome	4.16e-05	0.000221	CcSEcCtD
Cilostazol—Rash—Zonisamide—epilepsy syndrome	4.15e-05	0.00022	CcSEcCtD
Cilostazol—Infection—Pregabalin—epilepsy syndrome	4.14e-05	0.00022	CcSEcCtD
Cilostazol—Paraesthesia—Valproic Acid—epilepsy syndrome	4.14e-05	0.00022	CcSEcCtD
Cilostazol—Palpitations—Gabapentin—epilepsy syndrome	4.14e-05	0.00022	CcSEcCtD
Cilostazol—Dermatitis—Zonisamide—epilepsy syndrome	4.14e-05	0.00022	CcSEcCtD
Cilostazol—Dizziness—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.00022	CcSEcCtD
Cilostazol—Nausea—Diazepam—epilepsy syndrome	4.12e-05	0.000219	CcSEcCtD
Cilostazol—Loss of consciousness—Gabapentin—epilepsy syndrome	4.12e-05	0.000218	CcSEcCtD
Cilostazol—Headache—Zonisamide—epilepsy syndrome	4.12e-05	0.000218	CcSEcCtD
Cilostazol—Dyspnoea—Valproic Acid—epilepsy syndrome	4.11e-05	0.000218	CcSEcCtD
Cilostazol—Diarrhoea—Carbamazepine—epilepsy syndrome	4.11e-05	0.000218	CcSEcCtD
Cilostazol—Angiopathy—Topiramate—epilepsy syndrome	4.11e-05	0.000218	CcSEcCtD
Cilostazol—Pruritus—Lamotrigine—epilepsy syndrome	4.11e-05	0.000218	CcSEcCtD
Cilostazol—Shock—Pregabalin—epilepsy syndrome	4.1e-05	0.000218	CcSEcCtD
Cilostazol—Nervous system disorder—Pregabalin—epilepsy syndrome	4.09e-05	0.000217	CcSEcCtD
Cilostazol—Cough—Gabapentin—epilepsy syndrome	4.09e-05	0.000217	CcSEcCtD
Cilostazol—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.08e-05	0.000217	CcSEcCtD
Cilostazol—Mediastinal disorder—Topiramate—epilepsy syndrome	4.08e-05	0.000216	CcSEcCtD
Cilostazol—Tachycardia—Pregabalin—epilepsy syndrome	4.07e-05	0.000216	CcSEcCtD
Cilostazol—Chills—Topiramate—epilepsy syndrome	4.06e-05	0.000216	CcSEcCtD
Cilostazol—Dyspepsia—Valproic Acid—epilepsy syndrome	4.06e-05	0.000215	CcSEcCtD
Cilostazol—Skin disorder—Pregabalin—epilepsy syndrome	4.05e-05	0.000215	CcSEcCtD
Cilostazol—Hypertension—Gabapentin—epilepsy syndrome	4.05e-05	0.000215	CcSEcCtD
Cilostazol—Vomiting—Clonazepam—epilepsy syndrome	4.03e-05	0.000214	CcSEcCtD
Cilostazol—Decreased appetite—Valproic Acid—epilepsy syndrome	4.01e-05	0.000213	CcSEcCtD
Cilostazol—Vomiting—Phenytoin—epilepsy syndrome	4e-05	0.000212	CcSEcCtD
Cilostazol—Rash—Clonazepam—epilepsy syndrome	4e-05	0.000212	CcSEcCtD
Cilostazol—Dermatitis—Clonazepam—epilepsy syndrome	3.99e-05	0.000212	CcSEcCtD
Cilostazol—Chest pain—Gabapentin—epilepsy syndrome	3.99e-05	0.000212	CcSEcCtD
Cilostazol—Arthralgia—Gabapentin—epilepsy syndrome	3.99e-05	0.000212	CcSEcCtD
Cilostazol—Myalgia—Gabapentin—epilepsy syndrome	3.99e-05	0.000212	CcSEcCtD
Cilostazol—Nausea—Felbamate—epilepsy syndrome	3.99e-05	0.000212	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.98e-05	0.000211	CcSEcCtD
Cilostazol—Vomiting—Oxcarbazepine—epilepsy syndrome	3.98e-05	0.000211	CcSEcCtD
Cilostazol—Anxiety—Gabapentin—epilepsy syndrome	3.98e-05	0.000211	CcSEcCtD
Cilostazol—Anorexia—Pregabalin—epilepsy syndrome	3.98e-05	0.000211	CcSEcCtD
Cilostazol—Dizziness—Carbamazepine—epilepsy syndrome	3.97e-05	0.000211	CcSEcCtD
Cilostazol—Diarrhoea—Lamotrigine—epilepsy syndrome	3.97e-05	0.000211	CcSEcCtD
Cilostazol—Headache—Clonazepam—epilepsy syndrome	3.97e-05	0.000211	CcSEcCtD
Cilostazol—Rash—Phenytoin—epilepsy syndrome	3.97e-05	0.00021	CcSEcCtD
Cilostazol—Dermatitis—Phenytoin—epilepsy syndrome	3.96e-05	0.00021	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.96e-05	0.00021	CcSEcCtD
Cilostazol—Rash—Oxcarbazepine—epilepsy syndrome	3.95e-05	0.000209	CcSEcCtD
Cilostazol—Pain—Valproic Acid—epilepsy syndrome	3.95e-05	0.000209	CcSEcCtD
Cilostazol—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.94e-05	0.000209	CcSEcCtD
Cilostazol—Headache—Phenytoin—epilepsy syndrome	3.94e-05	0.000209	CcSEcCtD
Cilostazol—Discomfort—Gabapentin—epilepsy syndrome	3.94e-05	0.000209	CcSEcCtD
Cilostazol—Headache—Oxcarbazepine—epilepsy syndrome	3.92e-05	0.000208	CcSEcCtD
Cilostazol—Nausea—Zonisamide—epilepsy syndrome	3.91e-05	0.000207	CcSEcCtD
Cilostazol—Hypotension—Pregabalin—epilepsy syndrome	3.9e-05	0.000207	CcSEcCtD
Cilostazol—Flatulence—Topiramate—epilepsy syndrome	3.89e-05	0.000206	CcSEcCtD
Cilostazol—Dizziness—Lamotrigine—epilepsy syndrome	3.84e-05	0.000204	CcSEcCtD
Cilostazol—Oedema—Gabapentin—epilepsy syndrome	3.82e-05	0.000203	CcSEcCtD
Cilostazol—Vomiting—Carbamazepine—epilepsy syndrome	3.82e-05	0.000203	CcSEcCtD
Cilostazol—Back pain—Topiramate—epilepsy syndrome	3.81e-05	0.000202	CcSEcCtD
Cilostazol—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.8e-05	0.000202	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.8e-05	0.000202	CcSEcCtD
Cilostazol—Infection—Gabapentin—epilepsy syndrome	3.8e-05	0.000202	CcSEcCtD
Cilostazol—Muscle spasms—Topiramate—epilepsy syndrome	3.79e-05	0.000201	CcSEcCtD
Cilostazol—Rash—Carbamazepine—epilepsy syndrome	3.79e-05	0.000201	CcSEcCtD
Cilostazol—Dermatitis—Carbamazepine—epilepsy syndrome	3.78e-05	0.000201	CcSEcCtD
Cilostazol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.77e-05	0.0002	CcSEcCtD
Cilostazol—Insomnia—Pregabalin—epilepsy syndrome	3.77e-05	0.0002	CcSEcCtD
Cilostazol—Nausea—Clonazepam—epilepsy syndrome	3.76e-05	0.0002	CcSEcCtD
Cilostazol—Headache—Carbamazepine—epilepsy syndrome	3.76e-05	0.0002	CcSEcCtD
Cilostazol—Shock—Gabapentin—epilepsy syndrome	3.76e-05	0.0002	CcSEcCtD
Cilostazol—Nervous system disorder—Gabapentin—epilepsy syndrome	3.75e-05	0.000199	CcSEcCtD
Cilostazol—Paraesthesia—Pregabalin—epilepsy syndrome	3.75e-05	0.000199	CcSEcCtD
Cilostazol—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.74e-05	0.000199	CcSEcCtD
Cilostazol—Nausea—Phenytoin—epilepsy syndrome	3.74e-05	0.000198	CcSEcCtD
Cilostazol—Tachycardia—Gabapentin—epilepsy syndrome	3.73e-05	0.000198	CcSEcCtD
Cilostazol—Dyspnoea—Pregabalin—epilepsy syndrome	3.72e-05	0.000197	CcSEcCtD
Cilostazol—Nausea—Oxcarbazepine—epilepsy syndrome	3.72e-05	0.000197	CcSEcCtD
Cilostazol—Skin disorder—Gabapentin—epilepsy syndrome	3.72e-05	0.000197	CcSEcCtD
Cilostazol—Vomiting—Lamotrigine—epilepsy syndrome	3.69e-05	0.000196	CcSEcCtD
Cilostazol—Urticaria—Valproic Acid—epilepsy syndrome	3.67e-05	0.000194	CcSEcCtD
Cilostazol—Rash—Lamotrigine—epilepsy syndrome	3.66e-05	0.000194	CcSEcCtD
Cilostazol—Ill-defined disorder—Topiramate—epilepsy syndrome	3.66e-05	0.000194	CcSEcCtD
Cilostazol—Dermatitis—Lamotrigine—epilepsy syndrome	3.66e-05	0.000194	CcSEcCtD
Cilostazol—Body temperature increased—Valproic Acid—epilepsy syndrome	3.65e-05	0.000193	CcSEcCtD
Cilostazol—Abdominal pain—Valproic Acid—epilepsy syndrome	3.65e-05	0.000193	CcSEcCtD
Cilostazol—Anorexia—Gabapentin—epilepsy syndrome	3.65e-05	0.000193	CcSEcCtD
Cilostazol—Anaemia—Topiramate—epilepsy syndrome	3.64e-05	0.000193	CcSEcCtD
Cilostazol—Headache—Lamotrigine—epilepsy syndrome	3.64e-05	0.000193	CcSEcCtD
Cilostazol—Decreased appetite—Pregabalin—epilepsy syndrome	3.63e-05	0.000192	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.6e-05	0.000191	CcSEcCtD
Cilostazol—Hypotension—Gabapentin—epilepsy syndrome	3.57e-05	0.00019	CcSEcCtD
Cilostazol—Nausea—Carbamazepine—epilepsy syndrome	3.57e-05	0.000189	CcSEcCtD
Cilostazol—Pain—Pregabalin—epilepsy syndrome	3.57e-05	0.000189	CcSEcCtD
Cilostazol—Malaise—Topiramate—epilepsy syndrome	3.56e-05	0.000189	CcSEcCtD
Cilostazol—Vertigo—Topiramate—epilepsy syndrome	3.54e-05	0.000188	CcSEcCtD
Cilostazol—Syncope—Topiramate—epilepsy syndrome	3.54e-05	0.000188	CcSEcCtD
Cilostazol—Leukopenia—Topiramate—epilepsy syndrome	3.53e-05	0.000187	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.48e-05	0.000185	CcSEcCtD
Cilostazol—Palpitations—Topiramate—epilepsy syndrome	3.48e-05	0.000185	CcSEcCtD
Cilostazol—Loss of consciousness—Topiramate—epilepsy syndrome	3.47e-05	0.000184	CcSEcCtD
Cilostazol—Insomnia—Gabapentin—epilepsy syndrome	3.46e-05	0.000183	CcSEcCtD
Cilostazol—Nausea—Lamotrigine—epilepsy syndrome	3.45e-05	0.000183	CcSEcCtD
Cilostazol—Cough—Topiramate—epilepsy syndrome	3.44e-05	0.000182	CcSEcCtD
Cilostazol—Feeling abnormal—Pregabalin—epilepsy syndrome	3.44e-05	0.000182	CcSEcCtD
Cilostazol—Paraesthesia—Gabapentin—epilepsy syndrome	3.43e-05	0.000182	CcSEcCtD
Cilostazol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.41e-05	0.000181	CcSEcCtD
Cilostazol—Dyspnoea—Gabapentin—epilepsy syndrome	3.41e-05	0.000181	CcSEcCtD
Cilostazol—Hypertension—Topiramate—epilepsy syndrome	3.4e-05	0.000181	CcSEcCtD
Cilostazol—Dyspepsia—Gabapentin—epilepsy syndrome	3.37e-05	0.000179	CcSEcCtD
Cilostazol—Arthralgia—Topiramate—epilepsy syndrome	3.36e-05	0.000178	CcSEcCtD
Cilostazol—Myalgia—Topiramate—epilepsy syndrome	3.36e-05	0.000178	CcSEcCtD
Cilostazol—Chest pain—Topiramate—epilepsy syndrome	3.36e-05	0.000178	CcSEcCtD
Cilostazol—Anxiety—Topiramate—epilepsy syndrome	3.35e-05	0.000177	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.33e-05	0.000177	CcSEcCtD
Cilostazol—Decreased appetite—Gabapentin—epilepsy syndrome	3.32e-05	0.000176	CcSEcCtD
Cilostazol—Discomfort—Topiramate—epilepsy syndrome	3.32e-05	0.000176	CcSEcCtD
Cilostazol—Urticaria—Pregabalin—epilepsy syndrome	3.31e-05	0.000176	CcSEcCtD
Cilostazol—Asthenia—Valproic Acid—epilepsy syndrome	3.31e-05	0.000176	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.3e-05	0.000175	CcSEcCtD
Cilostazol—Abdominal pain—Pregabalin—epilepsy syndrome	3.3e-05	0.000175	CcSEcCtD
Cilostazol—Body temperature increased—Pregabalin—epilepsy syndrome	3.3e-05	0.000175	CcSEcCtD
Cilostazol—Pain—Gabapentin—epilepsy syndrome	3.27e-05	0.000173	CcSEcCtD
Cilostazol—Pruritus—Valproic Acid—epilepsy syndrome	3.26e-05	0.000173	CcSEcCtD
Cilostazol—Oedema—Topiramate—epilepsy syndrome	3.22e-05	0.000171	CcSEcCtD
Cilostazol—Infection—Topiramate—epilepsy syndrome	3.2e-05	0.00017	CcSEcCtD
Cilostazol—Shock—Topiramate—epilepsy syndrome	3.17e-05	0.000168	CcSEcCtD
Cilostazol—Diarrhoea—Valproic Acid—epilepsy syndrome	3.16e-05	0.000167	CcSEcCtD
Cilostazol—Nervous system disorder—Topiramate—epilepsy syndrome	3.16e-05	0.000167	CcSEcCtD
Cilostazol—Feeling abnormal—Gabapentin—epilepsy syndrome	3.15e-05	0.000167	CcSEcCtD
Cilostazol—Thrombocytopenia—Topiramate—epilepsy syndrome	3.15e-05	0.000167	CcSEcCtD
Cilostazol—Tachycardia—Topiramate—epilepsy syndrome	3.14e-05	0.000167	CcSEcCtD
Cilostazol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.13e-05	0.000166	CcSEcCtD
Cilostazol—Skin disorder—Topiramate—epilepsy syndrome	3.13e-05	0.000166	CcSEcCtD
Cilostazol—Anorexia—Topiramate—epilepsy syndrome	3.07e-05	0.000163	CcSEcCtD
Cilostazol—Dizziness—Valproic Acid—epilepsy syndrome	3.05e-05	0.000162	CcSEcCtD
Cilostazol—Urticaria—Gabapentin—epilepsy syndrome	3.04e-05	0.000161	CcSEcCtD
Cilostazol—Body temperature increased—Gabapentin—epilepsy syndrome	3.02e-05	0.00016	CcSEcCtD
Cilostazol—Abdominal pain—Gabapentin—epilepsy syndrome	3.02e-05	0.00016	CcSEcCtD
Cilostazol—Hypotension—Topiramate—epilepsy syndrome	3.01e-05	0.000159	CcSEcCtD
Cilostazol—Asthenia—Pregabalin—epilepsy syndrome	2.99e-05	0.000159	CcSEcCtD
Cilostazol—Pruritus—Pregabalin—epilepsy syndrome	2.95e-05	0.000156	CcSEcCtD
Cilostazol—Vomiting—Valproic Acid—epilepsy syndrome	2.93e-05	0.000156	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.93e-05	0.000155	CcSEcCtD
Cilostazol—Insomnia—Topiramate—epilepsy syndrome	2.91e-05	0.000154	CcSEcCtD
Cilostazol—Rash—Valproic Acid—epilepsy syndrome	2.91e-05	0.000154	CcSEcCtD
Cilostazol—Dermatitis—Valproic Acid—epilepsy syndrome	2.91e-05	0.000154	CcSEcCtD
Cilostazol—Headache—Valproic Acid—epilepsy syndrome	2.89e-05	0.000153	CcSEcCtD
Cilostazol—Paraesthesia—Topiramate—epilepsy syndrome	2.89e-05	0.000153	CcSEcCtD
Cilostazol—Dyspnoea—Topiramate—epilepsy syndrome	2.87e-05	0.000152	CcSEcCtD
Cilostazol—Diarrhoea—Pregabalin—epilepsy syndrome	2.85e-05	0.000151	CcSEcCtD
Cilostazol—Dyspepsia—Topiramate—epilepsy syndrome	2.83e-05	0.00015	CcSEcCtD
Cilostazol—Decreased appetite—Topiramate—epilepsy syndrome	2.8e-05	0.000148	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.78e-05	0.000147	CcSEcCtD
Cilostazol—Dizziness—Pregabalin—epilepsy syndrome	2.76e-05	0.000146	CcSEcCtD
Cilostazol—Pain—Topiramate—epilepsy syndrome	2.75e-05	0.000146	CcSEcCtD
Cilostazol—Asthenia—Gabapentin—epilepsy syndrome	2.74e-05	0.000146	CcSEcCtD
Cilostazol—Nausea—Valproic Acid—epilepsy syndrome	2.74e-05	0.000145	CcSEcCtD
Cilostazol—Pruritus—Gabapentin—epilepsy syndrome	2.71e-05	0.000144	CcSEcCtD
Cilostazol—Vomiting—Pregabalin—epilepsy syndrome	2.65e-05	0.000141	CcSEcCtD
Cilostazol—Feeling abnormal—Topiramate—epilepsy syndrome	2.65e-05	0.000141	CcSEcCtD
Cilostazol—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.63e-05	0.00014	CcSEcCtD
Cilostazol—Rash—Pregabalin—epilepsy syndrome	2.63e-05	0.000139	CcSEcCtD
Cilostazol—Dermatitis—Pregabalin—epilepsy syndrome	2.63e-05	0.000139	CcSEcCtD
Cilostazol—Diarrhoea—Gabapentin—epilepsy syndrome	2.62e-05	0.000139	CcSEcCtD
Cilostazol—Headache—Pregabalin—epilepsy syndrome	2.61e-05	0.000139	CcSEcCtD
Cilostazol—Urticaria—Topiramate—epilepsy syndrome	2.56e-05	0.000136	CcSEcCtD
Cilostazol—Abdominal pain—Topiramate—epilepsy syndrome	2.54e-05	0.000135	CcSEcCtD
Cilostazol—Body temperature increased—Topiramate—epilepsy syndrome	2.54e-05	0.000135	CcSEcCtD
Cilostazol—Dizziness—Gabapentin—epilepsy syndrome	2.53e-05	0.000134	CcSEcCtD
Cilostazol—Nausea—Pregabalin—epilepsy syndrome	2.48e-05	0.000131	CcSEcCtD
Cilostazol—Vomiting—Gabapentin—epilepsy syndrome	2.43e-05	0.000129	CcSEcCtD
Cilostazol—Rash—Gabapentin—epilepsy syndrome	2.41e-05	0.000128	CcSEcCtD
Cilostazol—Dermatitis—Gabapentin—epilepsy syndrome	2.41e-05	0.000128	CcSEcCtD
Cilostazol—Headache—Gabapentin—epilepsy syndrome	2.4e-05	0.000127	CcSEcCtD
Cilostazol—Asthenia—Topiramate—epilepsy syndrome	2.31e-05	0.000122	CcSEcCtD
Cilostazol—Pruritus—Topiramate—epilepsy syndrome	2.28e-05	0.000121	CcSEcCtD
Cilostazol—Nausea—Gabapentin—epilepsy syndrome	2.27e-05	0.00012	CcSEcCtD
Cilostazol—Diarrhoea—Topiramate—epilepsy syndrome	2.2e-05	0.000117	CcSEcCtD
Cilostazol—Dizziness—Topiramate—epilepsy syndrome	2.13e-05	0.000113	CcSEcCtD
Cilostazol—Vomiting—Topiramate—epilepsy syndrome	2.05e-05	0.000109	CcSEcCtD
Cilostazol—Rash—Topiramate—epilepsy syndrome	2.03e-05	0.000108	CcSEcCtD
Cilostazol—Dermatitis—Topiramate—epilepsy syndrome	2.03e-05	0.000107	CcSEcCtD
Cilostazol—Headache—Topiramate—epilepsy syndrome	2.02e-05	0.000107	CcSEcCtD
Cilostazol—Nausea—Topiramate—epilepsy syndrome	1.91e-05	0.000101	CcSEcCtD
Cilostazol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	8.83e-06	0.000312	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	8.81e-06	0.000311	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.77e-06	0.000309	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	8.72e-06	0.000308	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	8.72e-06	0.000308	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NGF—epilepsy syndrome	8.67e-06	0.000306	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.66e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AQP1—epilepsy syndrome	8.55e-06	0.000302	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.53e-06	0.000301	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.53e-06	0.000301	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PFKL—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	8.5e-06	0.0003	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	8.48e-06	0.000299	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	8.44e-06	0.000298	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCR5—epilepsy syndrome	8.43e-06	0.000297	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.31e-06	0.000293	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NT5E—epilepsy syndrome	8.27e-06	0.000292	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALAD—epilepsy syndrome	8.27e-06	0.000292	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.26e-06	0.000291	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HTR2A—epilepsy syndrome	8.25e-06	0.000291	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.02e-06	0.000283	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.92e-06	0.000279	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.92e-06	0.000279	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.92e-06	0.000279	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.92e-06	0.000279	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.89e-06	0.000278	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.89e-06	0.000278	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TSC2—epilepsy syndrome	7.84e-06	0.000276	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AGT—epilepsy syndrome	7.83e-06	0.000276	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.8e-06	0.000275	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—AKT1—epilepsy syndrome	7.79e-06	0.000275	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—UPB1—epilepsy syndrome	7.77e-06	0.000274	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NEU1—epilepsy syndrome	7.77e-06	0.000274	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ATIC—epilepsy syndrome	7.77e-06	0.000274	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	7.73e-06	0.000273	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	7.73e-06	0.000273	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.72e-06	0.000272	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APOE—epilepsy syndrome	7.67e-06	0.000271	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	7.62e-06	0.000269	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.6e-06	0.000268	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.6e-06	0.000268	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.56e-06	0.000267	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KDR—epilepsy syndrome	7.52e-06	0.000265	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	7.48e-06	0.000264	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GLUL—epilepsy syndrome	7.41e-06	0.000262	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.36e-06	0.00026	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.36e-06	0.00026	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.34e-06	0.000259	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	7.28e-06	0.000257	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	7.25e-06	0.000256	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.25e-06	0.000256	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.25e-06	0.000256	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PRKCB—epilepsy syndrome	7.23e-06	0.000255	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.23e-06	0.000255	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.23e-06	0.000255	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—BCHE—epilepsy syndrome	7.22e-06	0.000255	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6ST—epilepsy syndrome	7.21e-06	0.000254	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.1e-06	0.00025	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.06e-06	0.000249	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.95e-06	0.000245	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.92e-06	0.000244	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	6.89e-06	0.000243	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.82e-06	0.000241	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.82e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.81e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.79e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TH—epilepsy syndrome	6.79e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.69e-06	0.000236	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.61e-06	0.000233	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.61e-06	0.000233	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—POMC—epilepsy syndrome	6.59e-06	0.000232	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.56e-06	0.000231	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.56e-06	0.000231	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.56e-06	0.000231	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.56e-06	0.000231	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.56e-06	0.000231	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCL2—epilepsy syndrome	6.45e-06	0.000227	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.44e-06	0.000227	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.44e-06	0.000227	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.35e-06	0.000224	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	6.3e-06	0.000222	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.26e-06	0.000221	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.14e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.14e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	6.14e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	6.1e-06	0.000215	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.08e-06	0.000214	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	6.01e-06	0.000212	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6e-06	0.000212	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6e-06	0.000212	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6e-06	0.000212	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.98e-06	0.000211	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.98e-06	0.000211	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.89e-06	0.000208	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGF2—epilepsy syndrome	5.83e-06	0.000206	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.78e-06	0.000204	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.77e-06	0.000204	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.67e-06	0.0002	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.67e-06	0.0002	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.59e-06	0.000197	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.58e-06	0.000197	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.58e-06	0.000197	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.57e-06	0.000196	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.51e-06	0.000194	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.5e-06	0.000194	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.5e-06	0.000194	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.45e-06	0.000192	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	5.44e-06	0.000192	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RELA—epilepsy syndrome	5.41e-06	0.000191	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MTOR—epilepsy syndrome	5.3e-06	0.000187	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.3e-06	0.000187	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.24e-06	0.000185	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	5.24e-06	0.000185	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BCHE—epilepsy syndrome	5.22e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.15e-06	0.000182	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.1e-06	0.00018	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GPX1—epilepsy syndrome	5.06e-06	0.000178	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.98e-06	0.000176	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.97e-06	0.000175	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.97e-06	0.000175	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.95e-06	0.000174	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.93e-06	0.000174	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.92e-06	0.000174	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TH—epilepsy syndrome	4.91e-06	0.000173	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—epilepsy syndrome	4.88e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.87e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.74e-06	0.000167	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.74e-06	0.000167	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—epilepsy syndrome	4.74e-06	0.000167	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.72e-06	0.000166	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.68e-06	0.000165	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.66e-06	0.000164	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.66e-06	0.000164	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.64e-06	0.000164	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—epilepsy syndrome	4.61e-06	0.000163	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.55e-06	0.00016	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.48e-06	0.000158	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—epilepsy syndrome	4.47e-06	0.000158	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.46e-06	0.000157	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.44e-06	0.000156	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.38e-06	0.000154	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.37e-06	0.000154	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APOE—epilepsy syndrome	4.35e-06	0.000153	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.34e-06	0.000153	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.34e-06	0.000153	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.27e-06	0.000151	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.26e-06	0.00015	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—epilepsy syndrome	4.25e-06	0.00015	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.25e-06	0.00015	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—epilepsy syndrome	4.14e-06	0.000146	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.1e-06	0.000145	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.09e-06	0.000144	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.05e-06	0.000143	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAT—epilepsy syndrome	4.04e-06	0.000143	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.04e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.97e-06	0.00014	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.93e-06	0.000139	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.85e-06	0.000136	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.81e-06	0.000134	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.8e-06	0.000134	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TH—epilepsy syndrome	3.8e-06	0.000134	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.74e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.73e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.73e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.71e-06	0.000131	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.7e-06	0.00013	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.68e-06	0.00013	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.66e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.65e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.59e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.59e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.54e-06	0.000125	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.5e-06	0.000124	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TH—epilepsy syndrome	3.49e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.4e-06	0.00012	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.33e-06	0.000117	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.32e-06	0.000117	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.21e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.17e-06	0.000112	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.16e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.15e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.14e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.13e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.04e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.98e-06	0.000105	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.97e-06	0.000105	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TH—epilepsy syndrome	2.96e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.93e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.91e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.91e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.87e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.86e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.84e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.83e-06	9.97e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	9.86e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.7e-06	9.52e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—epilepsy syndrome	2.64e-06	9.32e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.6e-06	9.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.56e-06	9.03e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.48e-06	8.74e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.47e-06	8.71e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.46e-06	8.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.44e-06	8.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.44e-06	8.59e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.43e-06	8.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.43e-06	8.56e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.37e-06	8.36e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.32e-06	8.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.29e-06	8.08e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TH—epilepsy syndrome	2.28e-06	8.05e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.28e-06	8.04e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.23e-06	7.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.2e-06	7.77e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.15e-06	7.59e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.09e-06	7.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.93e-06	6.81e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.92e-06	6.77e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.91e-06	6.72e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.9e-06	6.71e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.89e-06	6.67e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.88e-06	6.63e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.83e-06	6.45e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.75e-06	6.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.7e-06	6e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.66e-06	5.87e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.63e-06	5.73e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	5.4e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.5e-06	5.28e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.49e-06	5.26e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.48e-06	5.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.46e-06	5.15e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.3e-06	4.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.25e-06	4.43e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.14e-06	4.03e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.08e-06	3.82e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1e-06	3.53e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.36e-07	2.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.69e-07	2.71e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.52e-07	2.3e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.03e-07	1.77e-05	CbGpPWpGaD
